Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
What insurance typically covers FDA-approved peptides for approved indications: Semaglutide (Ozempic) for type 2 diabetes: Often covered Semaglutide (Wegovy) for obesity: Sometimes covered with restrictions Tirzepatide (Mounjaro) for type 2 diabetes: Often covered Tirzepatide (Zepbound) for obesity: Limited coverage What coverage looks like: Prior authorization typically required Documentation of failed dietary interventions BMI thresholds for weight loss indications Co-pays still substantial ($100-500 monthly) What insurance doesn't cover The vast majority of peptide therapy falls outside insurance coverage: Compounded peptides (BPC-157, TB-500, most growth hormone peptides) Anti-aging applications even for FDA-approved drugs Performance enhancement uses Off-label applications These costs are entirely out-of-pocket for most patients
Ozempic is approved to manage Type 2 diabetes, reduce the risk of heart attacks and strokes in people with heart disease, and reduce the risk of worsening kidney disease
Track your progress Whether its journaling or using an app, keeping tabs on your weight, appetite, and mood can help keep you motivated
Sleep improvements fade after 2-4 months without repeat cycle
" Wegovy demonstrated consistent weight loss results across 15,000+ participants in controlled clinical trials, providing predictable outcomes with standardized dosing." FDA Clinical Trial Data, 2021 What's the difference in active ingredients
